PERSPECTIVE OF THE PHARMACEUTICAL-INDUSTRY ON THE DEVELOPMENT OF NEW DRUGS FOR HEART-FAILURE

Authors
RAJFER SI
Citation
Si. Rajfer, PERSPECTIVE OF THE PHARMACEUTICAL-INDUSTRY ON THE DEVELOPMENT OF NEW DRUGS FOR HEART-FAILURE, Journal of the American College of Cardiology, 22(4), 1993, pp. 10000198-10000200
Citations number
7
Categorie Soggetti
Cardiac & Cardiovascular System
Journal title
Journal of the American College of Cardiology → ACNP
ISSN journal
07351097
Volume
22
Issue
4
Year of publication
1993
Supplement
A
Pages
10000198 - 10000200
Database
ISI
SICI code
0735-1097(1993)22:4<10000198:POTPOT>2.0.ZU;2-5
Abstract
Despite recent therapeutic advances, patients with heart failure have considerable morbidity and a markedly shortened life span. The prevale nce of heart failure increases with age and is the most common cause o f hospital admission in the elderly. In developing innovative remedies for this disorder, the scientific challenges, regulatory agencies' gu idelines, physician behavior and marketing requirements must be consid ered.